- Pharmaceutical companies
- Teva Pharmaceutical Industries
Teva Pharmaceutical Industries
Phone: +972 3-926-7267
Type | Public company |
---|---|
Traded as | TASE: TEVA NYSE: TEVA TA-35 Index Component |
Industry | Pharmaceutical |
Founded | 1901 (1901) |
Founder | Günther Friedländer Chaim Salomon Moshe Levin Yitschak Elstein |
Headquarters | Tel Aviv, Israel |
Key people | Richard Francis (President) and (CEO) Sol Barer (Chairman) Eli Kalif (CFO) |
Revenue | US$ 15.878 Billion (2021) |
Operating income | US$ 1.715 Billion (2021) |
Net income | US$ 0.417 Billion (2021) |
Total assets | US$ 47.666 Billion (2021) |
Total equity | US$ 11.244 Billion (2021) |
Number of employees | 37,537 (2021) |
Website | tevapharm.com teva.co.il |
Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world. In a complex world, Teva's mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health. We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,500 products is among the largest of any pharmaceutical company in the world. Nearly 200 million people in 60 countries benefit from one of Teva's quality medicines every day. We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterizes how we do business and approach medicine.
For detailed contact information visit location pages below.
Teva Pharmaceutical Industries's locations around the world
Clinical Trials sponsored by Teva Pharmaceutical Industries
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.ComplétéArthrose du genou ou de la hancheÉtats-Unis, Bulgarie, Chili, Colombie, Danemark, Estonie, Allemagne, Hong Kong, Hongrie, Italie, Lituanie, Mexique, Pérou, Pologne, Roumanie, Fédération Russe, Afrique du Sud, Espagne, Suède, Ukraine, Royaume-Uni
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.ComplétéArthrose, Genou | Arthrose, HancheÉtats-Unis, Pologne, Royaume-Uni
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.ComplétéArthrose, Genou | Arthrose, HancheÉtats-Unis, Pologne, Hongrie, Espagne, Allemagne, Royaume-Uni, Danemark, Lituanie, Roumanie, Fédération Russe, Afrique du Sud, Ukraine
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.Complété
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.Résilié
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.RésiliéArthrose, Genou | Arthrose, HancheÉtats-Unis, Pologne, Royaume-Uni
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.ComplétéArthrose, Genou | Arthrose, HancheÉtats-Unis
-
Teva Pharmaceutical Industries, Ltd.RésiliéSclérose en plaques récurrente-rémittenteTchéquie, Allemagne, Hongrie, Israël, Italie, Pologne, Fédération Russe, Espagne, Royaume-Uni
-
Teva Pharmaceutical Industries, Ltd.ComplétéLa sclérose latérale amyotrophiqueBelgique, France, Allemagne, Israël, Italie, Royaume-Uni
-
Teva Pharmaceutical Industries, Ltd.RésiliéDéficit en hormone de croissanceBiélorussie, Bulgarie, Géorgie, Grèce, Hongrie, Israël, Pologne, Roumanie, Fédération Russe, Serbie, Espagne, Turquie, Ukraine